Boomers Should Not ...
Health Care: Drugs
GTx Inc. (GTXI: NASDAQ)
$6.30 -0.05 | -0.79%
05/22/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -27.08M | -33.29M | 15.29M | -46.26M |
| Operating Gains/Losses | -18.83M | 178.00K | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 972.00K | -298.00K | -88.00K | 669.00K |
| (Increase) Decrease in Inventories | 133.00K | -24.00K | -55.00K | -24.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 2.16M |
| (Decrease) Increase In Payables | 488.00K | 371.00K | -420.00K | -1.55M |
| (Decrease) Increase In Other Current Liabilities | 2.88M | 1.57M | -1.65M | -1.96M |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 5.07M |
| Other Non-Cash Items | 2.82M | -2.24M | -45.21M | -5.98M |
| Net Cash From Continuing Operations | -37.11M | -33.09M | -30.53M | -46.00M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -37.11M | -33.09M | -30.53M | -46.00M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 18.90M | 4.90M | 16.94M | 2.45M |
| Purchases of Property, Plant & Equipment | -142.00K | -54.00K | -95.00K | -600.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -11.98M | -15.14M | -8.57M | -11.28M |
| Other Cash from Investing Activities | 14.63M | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 21.40M | -10.30M | 8.28M | -9.42M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 85.00K | 49.04M | 40.30M | 136.00K |
| Repayment of Long-Term Debt | -82.00K | 0.00 | -88.00K | -5.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -85.00K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 3.00K | 48.95M | 40.21M | 131.00K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -15.70M | 5.56M | 17.96M | -55.29M |
Portfolios with GTXI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserJRC'S PICKS
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Trades for Seco...
- ContributorStocks With Big Insider Buy...
- Contributor10 Cheap Biotech Stocks Tha...
- UserRimp's Stockpicks
Latest GTXI Headlines from TheStreet
- 5 Health Care Stocks Under $10 Ready to Rip Higher 04.18.13 | 09:04 pm
- 4 Stocks Soaring on Unusual Volume 12.11.12 | 03:12 pm
- 5 Biotech Stocks Under $10 Blasting Higher 08.14.12 | 03:08 pm
- GTx's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 03:08 pm
- 7 Stocks Soaring in a Weak Market 05.08.12 | 02:05 pm
- 5 Stocks Insiders Love Right Now 03.15.12 | 01:03 pm
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- GTx Stock Gaps Down On Today's Open (GTXI) 02.21.12 | 08:02 am
- 5 Stocks With Big Insider Buying 07.01.11 | 02:07 pm
- Insiders Trading KIOR, NWN, GTXI 06.29.11 | 10:06 am
Press Releases for GTXI
- GTx-758 Poster Presentation Of Phase II Trial Data In Advanced Prostate Cancer Selected As One Of The Best Posters At The 28th Annual European Association Of Urology Congress - Business Wire 03.19.13 | 08:03 am
- Enobosarm Phase 2 Trial For Muscle Wasting And Physical Function In Patients With Cancer Published In The Lancet Oncology - Business Wire 03.14.13 | 07:03 am
- GTx Announces Webcast Of Corporate Presentation At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 07:02 am
- GTx Provides Corporate Update And Reports 2012 Financial Results - Business Wire 02.21.13 | 06:02 am
- GTx Announces Webcast Of Corporate Presentation At 2013 Citi Global Healthcare Conference - Business Wire 02.19.13 | 07:02 am
- GTx To Present Preclinical Data On A New Therapeutic Target In Prostate Cancer - Business Wire 02.14.13 | 07:02 am
- Novel Findings From Clinical Studies Examining The Effects Of Capesaris® (GTx-758) For The Treatment Of Advanced Prostate Cancer To Be Presented At 2013 American Society Of Clinical Oncology Genitourinary Cancer Symposium - Business Wire 02.13.13 | 07:02 am
- GTx Announces Webcast For Capesaris®(GTx-758) Analyst Day - Business Wire 02.12.13 | 07:02 am
- GTx, Inc. To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call And Webcast - Business Wire 02.07.13 | 07:02 am
- GTx Announces Webcast Of Corporate Presentation At Bio CEO & Investor Conference - Business Wire 02.05.13 | 07:02 am
Partner Headlines for GTXI
- Weekly CEO Sells Highlight: GTx, Inc, VIVUS, Inc, Time Warner Inc. - GuruFocus 07.23.12 | 01:07 am
- 3 Rallying Stocks Under $5 Being Bought Up By Company Insiders - Seeking Alpha 07.22.12 | 09:07 am
- Analyzing GTx, Inc.'s Vast Upside Potential - Seeking Alpha 03.26.12 | 09:03 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Calls Purchased on GTx, Inc. - Benzinga 06.20.11 | 01:06 pm
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Company News for April 14, 2011 - Corporate Summary - Zacks 04.14.11 | 10:04 am
- GTx Up Nearly 26% (GTXI) - Benzinga 04.13.11 | 09:04 am
- 20 Stocks Under $3 With Significant Insider Buying - Seeking Alpha 03.14.11 | 09:03 am
